Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 642

1.

N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

März W, Tiran B, Seelhorst U, Wellnitz B, Bauersachs J, Winkelmann BR, Boehm BO; LURIC Study Team.

Clin Chem. 2007 Jun;53(6):1075-83. Epub 2007 Apr 19.

2.

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.

N Engl J Med. 2005 Feb 17;352(7):666-75.

3.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

4.

Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study.

Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W.

Clin Chem. 2009 Jun;55(6):1135-46. doi: 10.1373/clinchem.2008.118844. Epub 2009 Apr 24.

5.

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.

J Am Soc Nephrol. 2007 Jan;18(1):321-30. Epub 2006 Dec 13.

6.

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.

Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM.

Intern Med J. 2009 Dec;39(12):812-8. doi: 10.1111/j.1445-5994.2009.01846.x.

PMID:
20233242
7.
8.

Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease.

Ndrepepa G, Braun S, Schömig A, Kastrati A.

Am J Cardiol. 2007 Aug 15;100(4):575-8. Epub 2007 Jul 3.

PMID:
17697808
9.

NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease.

Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH.

Clin Nephrol. 2009 Apr;71(4):380-6.

PMID:
19356370
10.

Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Am J Cardiol. 2007 Nov 15;100(10):1571-6.

PMID:
17996522
11.

[Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].

Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA.

Dtsch Med Wochenschr. 2008 Mar;133(12):564-9. doi: 10.1055/s-2008-1067282. German.

PMID:
18335382
12.

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.

Am J Cardiol. 2009 Aug 15;104(4):559-64. doi: 10.1016/j.amjcard.2009.04.023. Epub 2009 Jun 18.

PMID:
19660612
13.

Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.

Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2007 Apr 15;99(8):1051-4. Epub 2007 Mar 6.

PMID:
17437726
14.

Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study.

De Sutter J, De Bacquer D, Cuypers S, Delanghe J, De Buyzere M, Kornitzer M, De Backer G.

Eur Heart J. 2005 Dec;26(24):2644-9. Epub 2005 Oct 4.

PMID:
16204267
15.

Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.

Goei D, van Kuijk JP, Flu WJ, Hoeks SE, Chonchol M, Verhagen HJ, Bax JJ, Poldermans D.

Am J Cardiol. 2011 Feb 15;107(4):609-14. doi: 10.1016/j.amjcard.2010.10.021. Epub 2010 Dec 22.

PMID:
21185000
17.

Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.

Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.

Am J Cardiol. 2008 Jan 1;101(1):122-6.

PMID:
18157978
18.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

19.

Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.

Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A.

Crit Care Med. 2009 Jun;37(6):1837-44. doi: 10.1097/CCM.0b013e31819fe896.

PMID:
19384228
20.

Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.

Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.

Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.

PMID:
18678308

Supplemental Content

Support Center